The IBISCO survey: I. Multiphase discs and winds in the Seyfert galaxy Markarian 509

We present the analysis of the ALMA CO(2 1) emission line and the underlying 1.2mm continuum of Mrk 509 with spatial resolution of similar to 270 pc. This local Seyfert 1.5 galaxy, optically classified as a spheroid, is known to host an ionised disc, a starburst ring, and ionised gas winds on both nuclear (ultra-fast outflows) and galactic scales. From CO(2 1) we estimate a molecular gas reservoir of M-H2 = 1.7 x10(9) M-circle dot, located within a disc of size similar to 5.2 kpc, with M-dyn = (2.0 +/- 1.1) x 10(10) M-circle dot inclined at 44 +/- 10 deg. The molecular gas fraction within the disc is mu(gas) = 5%, consistent with that of local star-forming galaxies with similar stellar mass. The gas kinematics in the nuclear region within r similar to 700 pc, that is only marginally resolved at the current angular resolution, suggests the presence of a warped nuclear disc. Both the presence of a molecular disc with ongoing star formation in a starburst ring, and the signatures of a minor merger, are in agreement with the scenario where galaxy mergers produce gas destabilisation, feeding both star formation and AGN activity. The spatially resolved Toomre Q-parameter across the molecular disc is in the range Q(gas) = 0.5-10, and shows that the disc is marginally unstable across the starburst ring, and stable against fragmentation at nucleus and in a lopsided ring-like structure located inside of the starburst ring. We find complex molecular gas kinematics and significant kinematics perturbations at two locations, one within 300 pc of the nucleus and one 1.4 kpc away close to the region with high Q(gas), that we interpret as molecular winds with velocity v(98) = 200-250 km s(-1). The total molecular outflow rate is in the range 6.4-17.0 M-circle dot yr(-1) for the optically thin and thick cases, respectively. The molecular wind total kinetic energy is consistent with a multiphase momentum-conserving wind driven by the AGN with P-of/P-rad in the range 0.06-0.5. The spatial overlap of the inner molecular wind with the ionised wind, and their similar velocity suggest a cooling sequence within a multiphase wind driven by the AGN. The second outer molecular wind component overlaps with the starburst ring, and its energy is consistent with a supernova-driven wind arising from the starburst ring

Invoking Chiral Vector Leptoquark to explain LFU violation in B Decays

LHCb has recently reported more than $2\sigma$ deviation from the Standard Model prediction in the observable $R_{J/\psi}$. We study this anomaly in the framework of a vector leptoquark along with other lepton flavor universality violating measurements which include $R_{K^{(*)}}$, and $R_{D^{(*)}}$. We show that a chiral vector leptoquark can explain all the aforementioned anomalies consistently while also respecting other experimental constraints

Tau protein, A beta 42 and S-100B protein in cerebrospinal fluid of patients with dementia with Lewy bodies

The intra vitam diagnosis of dementia with Lewy bodies (DLB) is still based on clinical grounds. So far no technical investigations have been available to support this diagnosis. As for tau protein and beta-amyloid((1-42)) (Abeta42), promising results for the diagnosis of Alzheimer's disease ( AD) have been reported; we evaluated these markers and S-100B protein in cerebrospinal fluid (CSF), using a set of commercially available assays, of 71 patients with DLB, 67 patients with AD and 41 nondemented controls (NDC) for their differential diagnostic relevance. Patients with DLB showed significantly lower tau protein values compared to AD but with a high overlap of values. More prominent differences were observed in the comparison of DLB patients with all three clinical core features and AD patients. Abeta42 levels were decreased in the DLB and AD groups versus NDC, without significant subgroup differences. S-100B levels were not significantly different between the groups. Tau protein levels in CSF may contribute to the clinical distinction between DLB and AD, but the value of the markers is still limited especially due to mixed pathology. We conclude that more specific markers have to be established for the differentiation of these diseases. Copyright (C) 2005 S. Karger AG, Basel

Short-chain di-ureasil ormolytes doped with potassium triflate: Phase diagram and conductivity behavior

Di-urea cross-linked poly(oxyethylene)/siloxane hybrids, synthesized by the sol-gel process and containing a wide concentration range of potassium triflate, KCF3SO3, have been analyzed by x-ray diffraction and differential scanning calorimetry. The pseudo-phase diagram proposed has been taken into account in the interpretation of the complex impedance measurements. The xerogels prepared are obtained as transparent, thin monoliths . At room temperature the highest conductivity found was 2 x 10-6Scm-1.Fundação para a Ciência e a Tecnologia (FCT

Presence of Bisphenol A and Parabens in a Neonatal Intensive Care Unit: An Exploratory Study of Potential Sources of Exposure

This paper is part of the PhD thesis developed by L.M.I.-D. in the context of the“Clinical Medicineand Public Health Program”of the University of Granada.BACKGROUND:Newborns in neonatal intensive care units (NICUs) are in contact with a variety of medical products whose production might includesynthetic chemicals with hormonal activity.OBJECTIVES:Our aim was to assess the content of bisphenol A (BPA) and parabens (PBs) and the hormone-like activities of a subset of medical prod-ucts commonly used in NICUs in prolonged intimate contact with NICU newborns.METHODS:Fifty-two NICU items were analyzed, determining the concentrations of BPA and PBs [methyl- (MeP), ethyl- (EtP), propyl- (PrP), andbutylparaben (BuP)] and using the E-Screen and PALM-luciferase assays to measure thein vitro(anti-)estrogenic and (anti-)androgenic activity,respectively, of the extracts. Items found to have elevated BPA/PB content or hormone-like activities were further extracted using leachingmethodologies.RESULTS:BPA was found in three-fifths and PBs in four-fifths of tested NICU items, and∼25%and∼10%of extracts evidenced estrogenic andanti-androgenic activity, respectively. The highest BPA content was found in the three-way stopcock (>7:000 ng=g), followed by patterned transpar-entfilm dressing, gastro-duodenal feeding tubes, sterile gloves, single-lumen umbilical catheters, and intravenous (IV) infusion extension sets (con-centrations ranged from 100 to 700 ng=g BPA). A total PB concentration (PPBs) >100 ng=g was observed in several items, including light therapyprotection glasses, patterned transparentfilm dressing, winged IV catheters, IV infusion extension sets, and textile tape. The highest estrogenic activ-ity [>450 pM estradiol equivalent (E2eq)] was found in small dummy nipples, three-way stopcocks, and patterned transparentfilm dressing and thehighest anti-androgenic activity [>5 mM procymidone equivalent units per gram (Proceq=g)] in small dummy nipples and three-way stopcocksThis research was funded in part by grants from the European Union Commission (The European Human Biomonitoring Initiative H2020-EJP-HBM4EU), the Spanish Ministry of Economy and Competitiveness, Institute of Health Carlos III - FEDER (PI16/01820, PI16/01812, PI16/01858, PI17/01743, and PI17/01526), the Andalusia Regional Government (PI-0538-2017), and the Spanish Consortium for Research on Epidemiology and Public Health(CIBERESP). The authors are also grateful to the Carlos IIIInstitute of Health (ISCIII) for the predoctoral research contract(FI17/00316) granted to L.M.I.-D., the postdoctoral researchcontract granted to C.F. (Miguel Servet-FEDER fund MS16/00085), and the José María Segovia de Arana contract granted to N.O. (INT18/00060)

Acute exacerbation of idiopathic pulmonary fibrosis: International survey and call for harmonisation.

AIM Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is an often deadly complication of IPF. No focused international guidelines for the management of AE-IPF exist. The aim of this international survey was to assess the global variability in prevention, diagnostic and treatment strategies for AE-IPF. MATERIAL AND METHODS Pulmonologists with ILD expertise were invited to participate in a survey designed by an international expert panel. RESULTS 509 pulmonologists from 66 countries responded. Significant geographical variability in approaches to manage AE-IPF was found. Common preventive measures included antifibrotic drugs and vaccination. Diagnostic differences were most pronounced regarding use of KL-6 and viral testing, while HRCT, BNP and D-Dimer are generally applied. High dose steroids are widely administered (94%); the use of other immunosuppressant and treatment strategies is highly variable. Very few (4%) responders never use immunosuppression. Antifibrotic treatments are initiated during AE-IPF by 67%. Invasive ventilation or extracorporeal membrane oxygenation are mainly used as a bridge to transplantation. Most physicians educate patients comprehensively on the severity of AE-IPF (82%) and consider palliative care (64%). CONCLUSION Approaches to the prevention, diagnosis and treatment of AE-IPF vary worldwide. Global trials and guidelines to improve the prognosis of AE-IPF are needed

IGR J18249−3243: a new GeV-emitting FR II and the emerging population of high-energy radio galaxies

The advent of new all-sky radio surveys such as the VLA Sky Survey (VLASS) and the Rapid ASKAP Continuum Survey (RACS), performed with the latest generation radio telescopes, is opening new possibilities on the classification and study of extragalactic $\gamma$-ray sources, specially the underrepresented ones like radio galaxies. In particular, the enhanced sensitivity (sub-mJy level) and resolution (a few arcsec) provides a better morphological and spectral classification. In this work, we present the reclassification of a Fermi-LAT source as a new FRII radio galaxy from the INTEGRAL sample found to emit at GeV energies. Through a broad-band spectral fitting from radio to $\gamma$-ray, we find that the commonly invoked jet contribution is not sufficient to account for the observed $\gamma$-ray flux. Our modeling suggests that the observed emission could mainly originate in the lobes (rather than in the radio core) by inverse Compton scattering of radio-emitting electrons off the ambient photon fields. In addition, we cross-correlated the latest generation radio surveys with a list of Fermi-LAT objects from the literature considered to be candidate misaligned AGN, finding four new radio galaxies with a double-lobed morphology. Additional four objects could be classified as such thanks to previous studies in the literature, for a total of nine new radio galaxies with GeV emission presented in this work. We foresee that further objects of this class might be found in the near future with the advent of the Square Kilometer Array (SKA), populating the GeV sky

Building Virtual Earth Observatories using Ontologies and Linked Geospatial Data

TELEIOS is a European project that addresses the need for scalable access to petabytes of Earth Observation data and the discovery of knowledge that can be used in applications. To achieve this, TELEIOS builds on scientific database technologies (array databases, SciQL, data vaults), Semantic Web technologies (stRDF and stSPARQL) and linked geospatial data. In this technical communication we outline the TELEIOS advancements to the state of the art and give an overview of its technical contributions up to today

Malignancy following heart transplantation: differences in incidence and prognosis between sexes – a multicenter cohort study

[Abstract] Male patients are at increased risk for developing malignancy postheart transplantation (HT); however, real incidence and prognosis in both genders remain unknown. The aim of this study was to assess differences in incidence and mortality related to malignancy between genders in a large cohort of HT patients. Incidence and mortality rates were calculated for all tumors, skin cancers (SCs), lymphoma, and nonskin solid cancers (NSSCs) as well as survival since first diagnosis of neoplasia. 5865 patients (81.6% male) were included. Total incidence rates for all tumors, SCs, and NSSCs were lower in females [all tumors: 25.7 vs. 44.8 per 1000 person‐years; rate ratio (RR) 0.68, (0.60–0.78), P < 0.001]. Mortality rates were also lower in females for all tumors [94.0 (77.3–114.3) vs. 129.6 (120.9–138.9) per 1000 person‐years; RR 0.76, (0.62–0.94), P = 0.01] and for NSSCs [125.0 (95.2–164.0) vs 234.7 (214.0–257.5) per 1000 person‐years; RR 0.60 (0.44–0.80), P = 0.001], albeit not for SCs or lymphoma. Female sex was associated with a better survival after diagnosis of malignancy [log‐rank p test = 0.0037; HR 0.74 (0.60–0.91), P = 0.004]. In conclusion, incidence of malignancies post‐HT is higher in males than in females, especially for SCs and NSSCs. Prognosis after cancer diagnosis is also worse in males

Sarcoma treatment in the era of molecular medicine

Sarcomas are heterogeneous and clinically challenging soft tissue and bone cancers. Although constituting only 1% of all human malignancies, sarcomas represent the second most common type of solid tumors in children and adolescents and comprise an important group of secondary malignancies. More than 100 histological subtypes have been characterized to date, and many more are being discovered due to molecular profiling. Owing to their mostly aggressive biological behavior, relative rarity, and occurrence at virtually every anatomical site, many sarcoma subtypes are in particular difficult-to-treat categories. Current multimodal treatment concepts combine surgery, polychemotherapy (with/without local hyperthermia), irradiation, immunotherapy, and/or targeted therapeutics. Recent scientific advancements have enabled a more precise molecular characterization of sarcoma subtypes and revealed novel therapeutic targets and prognostic/predictive biomarkers. This review aims at providing a comprehensive overview of the latest advances in the molecular biology of sarcomas and their effects on clinical oncology; it is meant for a broad readership ranging from novices to experts in the field of sarcoma.Peer reviewe